|
Originally published In Press as doi:10.1074/jbc.M204605200 on August 2, 2002
J. Biol. Chem., Vol. 277, Issue 41, 38262-38271, October 11, 2002
Isolation and Biochemical Characterization of
Hypophosphite/ 2-Oxoglutarate Dioxygenase
A NOVEL PHOSPHORUS-OXIDIZING ENZYME FROM PSEUDOMONAS
STUTZERI WM88*
Andrea K.
White and
William W.
Metcalf
From the Department of Microbiology, University of Illinois,
Urbana, Illinois 61801
Received for publication, May 10, 2002, and in revised form, July 30, 2002
 |
ABSTRACT |
The htxA gene is required for
the oxidation of hypophosphite in Pseudomonas stutzeri WM88
(Metcalf, W. W., and Wolfe, R. S. (1998) J. Bacteriol. 180, 5547-5558). Amino acid sequence comparisons suggest that hypophosphite:2-oxoglutarate dioxygenase (HtxA) is a novel
member of the 2-oxoglutarate-dependent dioxygenase enzyme family. To provide experimental support for this hypothesis, HtxA was
overproduced in Escherichia coli and purified to apparent homogeneity. Recombinant HtxA is identical to the native enzyme based
on amino terminus sequencing and mass spectral analysis, and it
catalyzes the oxidation of hypophosphite to phosphite in a process
strictly dependent on 2-oxoglutarate, ferrous ions, and oxygen.
Succinate and phosphite are stoichiometrically produced, indicating a
strict coupling of the reaction. Size exclusion analysis suggests that
HtxA is active as a homodimer, and maximal activity is observed at pH
7.0 and at 27 °C. The apparent Km values for hypophosphite and 2-oxoglutarate were 0.58 ± 0.04 mM
and 10.6 ± 1.4 µM, respectively.
Vmax and kcat values
were determined to be 10.9 ± 0.30 µmol min 1
mg 1 and 355 min 1, respectively.
2-Oxoadipate and pyruvate substitute poorly for 2-oxoglutarate as a
cosubstrate. The highest specific activity is observed with
hypophosphite as substrate, but HtxA is also able to oxidize formate
and arsenite at significant rates. The substrate analog inhibitors,
formate and nitrate, significantly reduce HtxA activity.
 |
INTRODUCTION |
The current view of phosphorus metabolism
dictates that, unlike other elements essential for growth, phosphorus
does not undergo a biologically catalyzed oxidation-reduction cycle in
nature. The biochemistry involving this essential and often limiting
nutrient is typically thought to be restricted to the formation and
hydrolysis of phosphate esters, in which phosphorus exists in its most
oxidized state (P5+). However, the number of microorganisms
capable of using reduced phosphorus compounds as the sole source of
phosphorus or able to synthesize reduced phosphorus compounds clearly
demonstrates that this is not the case (1-5). Although microbial
metabolism of reduced phosphorus compounds has been documented in the
literature for several decades, it has remained unexplored in any
detail on either the biochemical or genetic levels until recently. This is especially true with respect to the microbial oxidation of the
reduced Pi compounds, phosphite (P3+) and
hypophosphite (P+).
Microbial growth on hypophosphite or phosphite as the sole source of
phosphorus has been reported in such microorganism as Escherichia
coli, Bacillus spp., Pseudomonas
fluorescens, Klebsiella aerogenes, and
Erwinia spp. (2, 4, 6-9); however, little is
known about the biochemistry of hypophosphite or phosphite oxidation in
these organisms. In P. fluorescens, activity of partially purified phosphorus-oxidizing enzyme was demonstrated to be
NAD+-dependent and specific for phosphite;
however, a more detailed analysis was not completed (10). Similarly,
hypophosphite oxidation was detected in cell extracts of Bacillus
caldolyticus, which was demonstrated to grow on hypophosphite as
the sole source of phosphorus (11). This enzyme was also partially
purified, but nothing is known about the reaction beyond the
requirement for NAD+; neither the responsible enzyme nor
the mechanism of hypophosphite oxidation was determined.
Recently we isolated Pseudomonas stutzeri WM88, an organism
with the ability to oxidize hypophosphite and phosphite (12). Genetic
analysis of hypophosphite and phosphite oxidation in P. stutzeri WM88 led to the identification of two regions of the chromosome involved in utilization of these compounds as the sole phosphorus sources, one region for the oxidation of hypophosphite and
the other for phosphite oxidation. Furthermore, these studies showed
that the genes involved in phosphite oxidation were also required for
growth on hypophosphite, suggesting that hypophosphite oxidation to
phosphate proceeds via a phosphite intermediate. Sequence analysis of
the chromosomal region for hypophosphite oxidation revealed five open
reading frames, htxABCDE, which appear to form a
transcriptional unit. Analysis of the predicted amino acid sequence of
the htxA gene product indicates that it is most similar to
members of the 2-oxoglutarate-dependent dioxygenase family,
having 26% identity to proline 4-hydroxylase from
Dactylosporangium (13). The putative htxBCDE
products likely comprise a binding protein-dependent
hypophosphite transporter. Of the five open reading frames identified,
only the htxA gene was required for hypophosphite oxidation
in P. stutzeri WM88. This, in addition to the amino acid
sequence similarities of hypophosphite:2-oxoglutarate dioxygenase
(HtxA)1 to members of the
2-oxoglutarate-dependent dioxygenase family of enzymes,
strongly suggests that htxA encodes a novel enzyme responsible for hypophosphite oxidation, HtxA. Sequence analysis of the
phosphite oxidation region suggested the presence a binding protein-dependent phosphite transporter, encoded by
ptxABC, and an NAD:phosphite oxidoreductase (PtxD), encoded
by ptxD (12).
Based on these data, a biochemical pathway for the oxidation of
hypophosphite to phosphate was proposed (Fig.
1) (12). In this pathway hypophosphite is
first oxidized to phosphite by the HtxA protein. The phosphite produced
in this reaction is subsequently oxidized to phosphate by the PtxD
protein. Strong biochemical evidence has been provided for the second
step in this putative pathway (14, 15). The responsible enzyme, PtxD,
has been characterized in pure form. This enzyme is highly specific for
its substrates and stoichiometrically produces phosphate and NADH from
phosphite and NAD+. However, biochemical support for the
initial step, oxidation of hypophosphite to phosphite, has yet to be
provided. In this paper we address this deficiency by reporting the
purification and initial biochemical characterization of HtxA, thus
completing the first biochemical characterization of a pathway for the
oxidation of the reduced inorganic phosphorus compounds.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Proposed biochemical pathway for the
oxidation of hypophosphite to phosphate in P. stutzeri
WM88. HtxA is a novel member of the
2-oxoglutarate-dependent dioxygenase superfamily of enzymes
and catalyzes the oxidation of hypophosphite to phosphite requiring
2-oxoglutarate and oxygen as cosubstrates in addition to ferrous ions
for activity. The reaction proceeds by the incorporation of one of the
atoms of dioxygen into hypophosphite to form phosphite. The other atom
of dioxygen reacts with 2-oxoglutarate, resulting in oxidative
decarboxylation giving rise to succinate and CO2. PtxD is a
member of the D-isomer-specific 2-hydroxy acid
NAD-dependent dehydrogenase protein family (15). This
enzyme completes the oxidation of hypophosphite by oxidizing phosphite
to phosphate using NAD+ as a cofactor.
|
|
 |
EXPERIMENTAL PROCEDURES |
Bacterial Strains and Culture Conditions--
E. coli
DH5 (16) was used as a host for cloning experiments and as a host
for vector pMAL-c2X (New England Biolabs Inc., Beverly, MA) and its
derivatives. E. coli BL21(DE3) (17) was used as a host for
expression vector pETlla (Novagen, Madison, WI) and its derivatives.
E. coli strains were grown in Luria-Burtani medium with
either 100 µg/ml ampicillin or 50 µg/ml carbenicillin when
appropriate. P. stutzeri strain WM536 is a spontaneous
smooth colony mutant of the original phosphite and hypophosphite-
oxidizing isolate, WM88, and P. stutzeri WM567 is a
spontaneous streptomycin-resistant derivative of WM536 (12). P. stutzeri strains were grown in either Luria-Bertani medium or MOPS
minimal medium with 0.4% glucose and the appropriate phosphorus source
(18). Phosphorus solutions were made fresh and sterilized by filtration
immediately before use. For large scale expression of native or
recombinant proteins, cultures were grown in a 30-liter stainless steel
bioreactor (model P30A, B. Bruan Biotech, Allentown, PA) at 30 °C.
To remove residual phosphate remaining after the cleaning processes,
all glassware for growth and media preparation was soaked in ultrapure
deionized water with several changes. The bioreactor vessel was washed
additionally with 0.1 M nitric acid and rinsed with
ultrapure deionized water. For the preparation of phosphate-free solid
glucose MOPS minimal medium, the agar was rinsed before use with
several changes of ultrapure deionized water.
Construction of HtxA Expression Vector pAG4--
Standard
methods for DNA manipulation and cloning were used throughout (19).
Plasmid pAG4, which carries HtxA under control of the T7 promoter, was
constructed by PCR amplification of the htxA gene from
P. stutzeri WM88 chromosomal DNA using Taq
polymerase (Invitrogen) and the following primers:
5'-GCGCGCGCCATATGTTTGCAGAGCAGCAACGC-3', which
introduces an NdeI site at the translational start codon, and 5'-GGATCCCCTCAGTGAGTTAAAGAC-3', which
introduces a BamHI site just past the translational stop
codon of htxA (restriction sites are underlined). The
resulting PCR product was digested with NdeI and
BamHI and ligated into the same sites of vector pET11a
(Novagen). The sequence of the cloned htxA gene was
determined using standard T7 promoter and terminator primers and was
identical to the sequence determined previously.
Construction of Maltose-binding Protein (MBP)-PtxD Fusion
Expression Vector--
The ptxD gene was amplified by PCR
using Pfu Turbo polymerase (Statagene Cloning Systems, La
Jolla, CA) and pWM237 (12) as the template, with the following primers:
5'-ATGCTGCCGAAACTCGTTATAACTCACC-3' and
5'-GGATCCAAGCTTTCAACATGCGGCAGGCTCGG-3'. The reverse primer introduces a HindIII restriction site (underlined)
immediately after the ptxD translational stop codon. The PCR
fragment was digested with HindIII and cloned into the
XmnI-HindIII site of the MBP fusion vector
pMAL-c2X (New England Biolabs), creating pAW32. Creation of the correct
fusion was verified by sequencing using the malE and M13/pUC
sequencing primers (New England Biolabs).
Construction of htx Promoter-lacZ Fusion Strain, WM2940--
The
1.0-kbp region of DNA directly upstream from the htxA
ribosomal binding site was amplified by PCR using Taq
polymerase (Invitrogen) and the following primers:
5'-GGCGGCACTAGTGGATCCCCGATTCGTACCGGGTGGC-3', which
introduces an SpeI site, and
5'-GGATCCGCGGCCGCAAGGTCTTCCAACGAATAATC-3', which introduces
an NotI restriction site for facilitation of cloning
(restriction sites underlined). The resulting PCR product was digested
with the appropriate enzymes and ligated into the same sites of the
broad host range cloning vector pWM263 (12) to create pAW35. The
lacZ gene was amplified from E. coli genomic DNA
using Taq polymerase and the following primers:
5'-GGCGGCGCGGCCGCAGGAAACAGCTATGACCATG-3' and
5'-GGCGGCGCGGCCGCTTATTTTTGACACCAGACCA-3', which insert
NotI sites at the 5'- and 3'-ends of the PCR product (sites
underlined). The resulting product was digested with NotI
and inserted into the same site of pAW35 to create pAW36. Construction
of the correct transcriptional htx promoter-lacZ
fusion was verified by DNA sequencing. Plasmid pAW36 was transformed
into the transfer-competent E. coli strain BW20767 (20) with
selection for ampicillin resistance, followed by mating of the
transformants with P. stutzeri strain WM567 with selection
on glucose MOPS minimal medium containing ampicillin as described
previously (21). For expression analysis of the htx
promoter-lacZ fusion, a P. stutzeri exconjugate
(WM2940) harboring pAW36 was grown on glucose MOPS minimal medium
containing carbenicillin and either 2 mM Pi and
0.15% glucose (excess phosphorus) or 0.1 mM phosphite,
phosphate, or hypophosphite and 1% glucose (limiting phosphorus).
Cells were harvested at stationary phase (A600
about 1.0) by centrifugation, and extracts were made as described above, using -galactosidase buffer (50 mM
Tris-Cl, pH 8.0, 10 mM KCl, 1 mM
MgSO4, 50 mM -mercaptoethanol) to resuspend the cells. Continuous -galactosidase assays were performed in a 1-ml
volume of -galactosidase buffer with the addition of 2.7 mM o-nitrophenyl- -D-galactoside
and 0.05 ml of extract containing about 0.1 mg of protein. Activity was
monitored as an increase in absorption at 420 nm.
Expression and Purification of MBP-PtxD--
WM2021 (E. coli DH5 transformant harboring pAW32) was grown in 30 liters
of Luria-Burtani medium, 0.2% glucose medium with carbenicillin in a
30-liter stainless steel bioreactor at 25 °C. The culture was
induced for expression at an A600 of about 0.4 by the addition of isopropyl-1-thio- -D-galactopyranoside
(IPTG) to a final concentration of 0.3 mM and was incubated
additionally at 25 °C for 12 h, then harvested by
centrifugation. Preparation of cell extracts and all purification steps
were performed at 4 °C. Approximately 26 g (wet weight) of cell
paste was resuspended in 40 ml of column buffer (20 mM
MOPS, 10% glycerol, 100 mM NaCl, 1 mM
dithiothreitol, pH 7.4) with the addition of about 15 mg of DNase I,
and the cells were broken by passage through a French pressure cell
twice at 12,000 p.s.i. The lysate was centrifuged at 20,000 × g for 30 min, and the supernatant was centrifuged further at
270,000 × g for 45 min to separate the soluble portion of the extract from the membrane components. The supernatant was recovered to obtain the high speed extract that was used in subsequent purification steps.
High speed extract containing about 300 mg of protein at 3 mg/ml was
loaded at 0.75 ml/min onto a 2.5-cm (inner diameter) × 20-cm
amylose/agarose column (New England Biolabs) preequilibrated in column
buffer. Unbound protein was removed with about 10 column volumes of
column buffer at 1.5 ml/min until protein was no longer detected in the
eluent by UV absorption at 280 nm. MBP-PtxD was eluted with column
buffer containing 20 mM maltose at a flow rate of 1.5 ml/min. The purest fractions determined by SDS-PAGE analysis and
specific activity were pooled, desalted, and concentrated in an
ultrafiltration cell (Amicon Inc., Beverly, MA) equipped with an Amicon
DiaFlow membrane with molecular exclusion size of 10,000 Da. Purified
MBP-PtxD was stored at 70 °C in 20 mM MOPS, 10%
glycerol, 1 mM dithiothreitol, pH 7.25.
Expression and Purification of Recombinant HtxA--
WM804
(E. coli BL21(DE3) harboring pAG4) was grown at 37 °C in
a 30-liter stainless steel bioreactor in Luria-Burtani medium containing carbenicillin. Protein expression was induced when the
culture reached mid-log phase (A600 about 0.6)
by the addition of IPTG to a final concentration of 1 mM.
The cells were incubated for an additional 1.5 h and harvested by centrifugation.
Crude extracts were prepared by resuspending about 8 g of cells
(wet weight) in 20 ml of buffer A (20 mM MOPS, 10%
glycerol, 75 mM NaCl, pH 8.0). Approximately 10 mg of DNase
I was added, and the cells were broken by passage through a French
pressure cell twice at 12,000 p.s.i. High speed extracts were obtained as described above.
Chromatography for the purification of both recombinant and native HtxA
was performed using AKTA fast protein liquid chromatography (Amersham
Biosciences) at 4 °C. Recombinant HtxA was purified on a 10-mm
(inner diameter) × 100-mm POROS® HQ anion exchange column (PerSeptive Biosystems, Inc. Framingham, MA), preequilibrated in
buffer A, by applying high speed extract containing about 200 mg of
protein at 24 mg/ml at 0.5 ml/min. Unbound protein was removed with 40 column volumes of buffer A at 3.0 ml/min. Recombinant HtxA was eluted
with a 30-column volume linear gradient of 75-300 mM NaCl
in 20 mM MOPS, 10% glycerol, pH 8.0, collecting 2.0-ml fractions. The purest fractions determined by HtxA specific activity and SDS-PAGE analysis were pooled, desalted, and concentrated using the
ultrafiltration cell and membrane described above. The purest pools
from five such purifications were combined and stored at 70 °C in
20 mM MOPS, 15% glycerol, pH 7.25, for use in the studies
described below.
Expression and Purification of Native HtxA--
For the
expression of HtxA in its native host, 30 liters of P. stutzeri WM567 was grown in a 30-liter bioreactor at 30 °C in
MOPS minimal medium containing 0.4% glucose, 2 mM
hypophosphite, and Antifoam 289 (Sigma). Cells were
harvested at stationary phase (A600 about 1.4)
by centrifugation. Approximately 25 g of cells was resuspended in
60 ml of buffer B (20 mM MOPS, 10% glycerol, pH 8.0).
Crude and high speed extract were prepared as described above.
Purification of native HtxA from P. stutzeri WM567 required
a three-step purification procedure. High speed extract containing about 300 mg of protein was loaded at a flow rate of 1.5 ml/min onto a
Hi Prep 16/10 DEAE-Sepharose column (Amersham Biosciences) preequilibrated in buffer B. Unbound sample was removed with 5 column
volumes of buffer B. HtxA was eluted from the column with a linear
0-0.4 M NaCl gradient in buffer B over 40 column volumes. The purest fractions based on SDS-PAGE analysis and specific activity of HtxA were pooled, desalted into buffer B, and concentrated using a
Centriprep 30 concentrator (Amicon). The concentrated pools of three
such purifications were then loaded onto a 4.6-mm (inner diameter) × 250-mm POROS HQ anion exchange column at a flow rate of 2.0 ml/min. Unbound protein was removed with 5 column volumes buffer B, and
HtxA was eluted with a linear 0-0.4 M NaCl gradient in
buffer B, over 30 column volumes. The purest fractions from two such
purifications were pooled, concentrated, and desalted into buffer B and
loaded onto a 4.6-mm (inner diameter) × 250-mm POROS
NH-2-oxoglutarate affinity column (see below) at a flow rate of 2.0 ml/min. Unbound protein was removed with 5 column volumes buffer B, and
HtxA was eluted with a linear 0-100 mM 2-oxoglutarate gradient over 40 column volumes. The purest fractions were pooled, concentrated, and desalted into 20 mM MOPS, 10% glycerol,
pH 7.2, using a Centriprep 30 concentrator, and stored at 70 °C
for future use.
Coupling 2-Oxoglutarate to POROS NH Affinity
Resin--
To make a 2-oxoglutarate cosubstrate affinity column for
the purification of native HtxA, 2-oxoglutarate was randomly coupled to
POROS NH activated affinity resin as follows. POROS NH
powder (2.7 g) was resuspended in 13.5 ml of 0.1 M
2-oxoglutarate in deionized water at pH 5.0. With continuous stirring,
1.5 ml of 1.0 M EDAC was slowly added to the slurry to a
final concentration of 0.1 M. The pH was periodically
adjusted back to 5.0 with 2.0 M NaOH during the 1st h of
the reaction until stabilized. The mixture was gently mixed for 24 h at room temperature. After the 24-h period, the coupled resin was
washed with 750 ml of 0.1 M Tris, pH 8.3, containing 0.5 M NaCl to remove unreacted substrates. Tris was replaced
with deionized water, and the coupled resin was packed into the column.
Gel Filtration to Determine the Native Size of
HtxA--
Molecular weight analysis of purified, recombinant HtxA was
performed on a Superdex 200 preparation grade Hi Load 16/60 size exclusion column (Amersham Biosciences). A mixture of 3.3 mg of purified HtxA and the following gel filtration standards (Bio-Rad): bovine thyroglobin (670,000), bovine -globulin (158,000), chicken ovalbumin (44,000), horse myoglobin (17,000), and vitamin
B12 (1,350) was chromatographed at a flow rate of 0.3 ml/min with 20 mM MOPS, 10% glycerol, 0.1 M
NaCl, pH 7.0, as the mobile phase.
Amino Terminus Sequencing and Mass Spectrometry--
Partially
purified recombinant and native HtxA were separated from contaminating
proteins on a 12% Tris-HCl precast polyacrylamide gel (Bio-Rad) under
denaturing conditions. The protein was transferred to a Sequi-Blot
polyvinylidene difluoride membrane (Bio-Rad) using a Mini Trans-Blot
Electrophoretic Transfer Cell (Bio-Rad) in 10 mM CAPS, 10%
methanol buffer, pH 11.0. Protein bands were visualized with Coomassie
Blue, and the membranes were submitted to the University of Illinois
Protein Sciences Facility for amino terminus sequencing by Edman
degradation. Matrix-assisted laser desorption ionization mass
spectrometry was performed at the University of Illinois Mass
Spectrometry facility using a Voyager-DE STR mass spectrometer (PerSeptive Biosystems).
Enzyme Activity Assays--
For purification and
characterization of HtxA, a continuous coupled spectrophotometric assay
using MBP-PtxD as a reporter enzyme was used. Activity was measured by
NADH production monitored as an increase in absorbance at 340 nm. The
extinction coefficient of 6,220 M 1
cm 1 was used to calculate NADH production, and enzyme
activities are given in standard enzyme units (µmol of NADH
produced/min). The standard assay mixture contained 20 mM
MOPS, pH 7.0, 1 mM 2-oxoglutarate, 2 mM
hypophosphite, 1 mM NAD+, 20 µM
FeCl2, 0.2-1 mg of purified PtxD, and 5-10 µg of
purified HtxA in a 1.0-ml volume. All activity assays were done at room temperature unless otherwise stated. Because HtxA activity rapidly diminishes in assay buffer (significant loss is observed within first 2 min at low protein concentrations) spectrophotometric data were
collected once/s for 1-2 min. Only the linear portion of the curve,
which was typically about 20 s, was used in activity calculations.
Anaerobic activity assays were done using substrate and enzyme
solutions, which were made anaerobic with multiple cycles of
alternating vacuum and nitrogen gas exchange; the assays were carried
out in gas-tight cuvettes. For the determination of pH optimum, 100 mM Tris, 50 mM glacial acetic acid, 50 mM MES buffer was used, and the pH was adjusted
appropriately with HCl or NaOH. The ionic strength of this buffer
remained constant over the pH range tested (22). Stoichiometry studies
and analysis of the use of alternative substrates were done by
measuring succinate production in an end point assay using a
commercially available kit (Roche Molecular Biochemicals).
31P NMR Assays--
31P NMR spectra were
acquired with a Varian Unity 500 equipped with a 5 mm Nalorac QUAD
probe at the Varian Oxford Instruments Center for Excellence in NMR
Laboratory at the University of Illinois. The HtxA assay solution
contained 20 mM MOPS, pH 7.0, 5 mM
hypophosphite, 3 mM 2-oxoglutarate, 100 µM
FeCl2, and 0.5 mg/ml HtxA in a 3-ml volume. A similar assay
without HtxA was used as the enzyme-free control. Both mixtures were
incubated with constant mixing at room temperature for about 2 h,
after which samples were removed, D2O was added to 10%
final concentration, and the samples were analyzed with 31P
NMR. The phosphite only standard contained 5 mM
phosphite in 20 mM MOPS buffer. Proton-coupled
31P spectra were acquired with an acquisition time of 0.655 s with 2,000 transients and using a pulse width of 5.2 µs. An
external reference of 85% phosphoric acid set at 0 ppm was used.
Other Methods--
Protein concentration was determined using
Coomassie Plus reagent (Pierce Chemical Co.) with bovine serum albumin
as the standard and following manufacturer's instructions. SDS-PAGE
was done in a Mini-PROTEAN II Cell (Bio-Rad) using 12% polyacrylamide
slab gels and the Laemmli buffer system (23). DNA sequencing was performed at the W. M. Keck Center for Comparative and Functional Genomics, University of Illinois.
 |
RESULTS |
Hypophosphite Oxidation Is Catalyzed by HtxA Protein--
To
demonstrate that htxA encodes a protein that catalyzes the
oxidation of hypophosphite to phosphite in a
2-oxoglutarate-dependent manner, a coupled continuous HtxA
activity assay was developed using MBP-PtxD as a reporter enzyme.
Accordingly, enzymatic oxidation of hypophosphite to phosphite is
coupled to phosphite-dependent NAD+ reduction,
which is monitored at 340 nm (see Fig. 1). However, using this assay,
hypophosphite oxidation could not consistently be detected in crude
extract of P. stutzeri WM88 grown on hypophosphite as the
sole source of phosphorus; therefore, HtxA was overproduced in
E. coli. Cell extract from E. coli
WM804, in which HtxA is overexpressed, catalyzes hypophosphite
oxidation with a specific activity of 2.40 units/mg. This activity is
strictly dependent on the addition of 2-oxoglutarate and ferrous ions
and was not detected in extract from E. coli BL21(DE3)
harboring the pET11a expression vector only. These data strongly
support the hypothesis that HtxA is a
2-oxoglutarate-dependent hypophosphite dioxygenase.
Purification of Recombinant and Native HtxA--
Overexpression in
E. coli BL21(DE3) produces very high levels of soluble HtxA
in the IPTG-induced extracts allowing about 95% homogeneous protein to
be obtained after a single anion exchange chromatography step (Table I and Fig.
2). Further purification using
2-oxoglutarate cosubstrate affinity chromatography was not helpful and
resulted in significant loss in activity accompanied by an
insignificant increase in purity. Additional purification attempts,
including anaerobic purification, also resulted in a significant and
irreversible loss of activity.
View this table:
[in this window]
[in a new window]
|
Table I
Representative purification of HtxA from E. coli
BL21(DE3)/pAG4
Cell growth and purification of HtxA are described under
"Experimental Procedures."
|
|

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 2.
SDS-PAGE analysis of HtxA purification.
One-step anion exchange chromatography results in about 95% pure HtxA.
Lanes 1 and 7, low range molecular mass markers
(kDa). Lane 2, extract from cells before induction with
IPTG. Lane 3, 10 µg of crude extract after IPTG induction.
Lane 4, 10 µg of cell-free crude extract. Lane
5, 5 µg of high speed extract. Lane 6, 5 µg of the
purest fraction from POROS HQ chromatography.
|
|
The nucleotide sequence of htxA revealed the presence of two
putative translation start sites for HtxA which would change the size
of the protein by 14 amino acids. To ensure that the recombinant form
of HtxA was expressed from the correct translational start site and
that it is identical to the native enzyme isolated from P. stutzeri WM536, attempts to purify native HtxA were made. Extracts
of P. stutzeri WM536 grown with 2 mM
hypophosphite as the sole source of phosphorus were fractionated with
tandem anion exchange chromatography followed by 2-oxoglutarate
affinity chromatography. Partially purified HtxA was obtained (about
30% homogeneity) and subjected to amino terminus sequencing and mass
spectral analysis. The amino-terminal sequence of both the native and
recombinant forms of the enzyme was determined to be MFAEQQREYLDKGYT,
which is in complete agreement with the predicted amino acid sequence of htxA (as annotated in GenBank, accession no. AFO61267). Mass spectral analysis yielded peaks at 32,485 ± 40 and
32,475 ± 40 Da for the native and recombinant forms of HtxA,
respectively, which are consistent with the predicted molecular mass of
the monomer of 32,503 Da. Based on these analyses, the native and recombinant forms of the enzyme are indistinguishable, and recombinant HtxA was used in all further studies.
HtxA Is a 2-Oxoglutarate-dependent Hypophosphite
Dioxygenase--
Purified HtxA demonstrates a strict requirement for
ferrous ions, oxygen, 2-oxoglutarate, and hypophosphite for activity
(Fig. 3). Only in the presence of all of
the components required for the continuous coupled assay was an
increase in absorbance at 340 nm observed. The end products succinate
and phosphite were produced in equimolar quantities, demonstrating a
1:1 stoichiometry for the reaction, with 0.524 ± 0.032 mol of
succinate/0.510 ± 0.010 mol of phosphite (as measured by
PtxD-catalyzed NADH production) produced after a 20-min incubation
time. Given the strict substrate specificity of PtxD determined in a
previous study (15), it seems evident that phosphite is the phosphorus
product of the HtxA reaction. However, to identify the product of the
HtxA reaction unequivocally, 31P NMR was used to analyze
the reaction products (Fig. 4). With the
addition of 3 mM 2-oxoglutarate in the assay, 2.85 mM phosphite was produced in the complete assay mixture
(Fig. 4C). These data show that phosphite is the only
phosphorus product made upon incubation of hypophosphite with HtxA and
that phosphite production is stoichiometric with 2-oxoglutarate
consumption.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
HtxA is a
2-oxoglutarate-dependent dioxygenase. Detection of
HtxA activity is dependent on the presence of all HtxA and PtxD assay
components. The complete assay consists of 20 mM MOPS, pH
7.0, 0.5 mM NAD+, 2 mM
hypophosphite, 0.5 mM 2-oxoglutarate, 20 µM
FeCl2, 1.4 units of PtxD, and 0.048 unit of HtxA.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
HtxA catalyzes the oxidation of hypophosphite
to phosphite as detected by 31P NMR. 31P
NMR was performed as described under "Experimental Procedures."
Each proton-coupled 31P NMR spectrum shows the following:
A, 5 mM phosphite standard showing the doublet
peak from the phosphite signal; B, sample taken from the no
enzyme control, showing the triplet peak of the hypophosphite signal;
C, sample from the complete assay mixture containing 20 mM MOPS, pH 7.0, 5 mM hypophosphite, 3 mM 2-oxoglutarate, 100 µM FeCl2,
and 0.5 mg/ml HtxA, showing both the hypophosphite triplet and the
phosphite doublet peaks. The vertical scale in each
panel is adjusted for each spectra individually.
|
|
Biochemical Characterization of Purified HtxA--
HtxA was
rapidly inactivated in assay buffer (see below); however, purified HtxA
was stable upon storage in 20 mM MOPS, 15% glycerol, pH
7.25 at 70 °C indefinitely and at 0 °C for several days. Size
exclusion analysis of the purified enzyme suggests a native molecular
mass of 68,794 Da, consistent with HtxA being active as a
homodimer (the amino acid sequence predicts a dimer molecular mass of
65,006 Da).
The optimal pH for HtxA was established using both a Universal buffer
system (100 mM Tris-Cl, 50 mM acetic acid, 50 mM MES), in which the ionic strength remains constant over
the pH range tested, and in 20 mM MOPS buffer. In both
buffers, the pH optimum was found to be 7.0; however, activity in MOPS
buffer was slightly higher and was sustained over a broader range of
pH, from 6.25 to 7.5 (Fig.
5A). Activity in BisTris and
phosphate buffers was much lower than what was observed in MOPS buffer
(data not shown), therefore, MOPS buffer was used in all
characterization studies. The temperature optimum was determined to be
between 25 and 30 °C with a broad range of activity from 15 to
35 °C (Fig. 5B). HtxA showed a marked decrease in
activity upon addition of NaCl at concentrations ranging from 25 to 300 mM (Fig. 5C).

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 5.
pH, temperature, and ionic requirements of
HtxA. The PtxD-coupled assay was used to determine the optimal pH,
temperature, and ionic requirements of HtxA. The assay
contained 1 mM NAD+, 2 mM
hypophosphite, 1 mM 2-oxoglutarate, 40 µM
FeCl2, 0.28-0.76 mg of PtxD, and 5.3-10.7 µg of
purified HtxA. All data points represent the averages of two identical
assays. A, the optimum pH was determined in both universal
buffer (100 mM Tris-Cl, 50 mM acetic acid, 50 mM MES) ( ) and in 20 mM MOPS ( ).
B, the optimum temperature was determined using 20 mM MOPS, pH 7.0, buffer containing 100 µg/ml bovine serum
albumin. C, the ionic requirements of HtxA were determined
in 20 mM MOPS buffer, pH 7.0.
|
|
As described above, maximal HtxA activity was shown to be dependent on
exogenous ferrous ions, although about 2% residual activity was
observed in the absence of exogenous Fe(II) (Table II). This is likely caused by small
amounts of remaining enzyme bound ferrous ions that were retained
during enzyme purification. FeCl2 concentrations ranging
from 20 to 120 µM supported full HtxA activity; however,
addition of EDTA to the reaction mixture completely abolished the
activity of HtxA. A variety of ferrous salts supported equal levels of
HtxA activity when provided at 100 µM (Table II). The
alternative divalent cations Ni(II), Co(II), Mn(II), Ca(II), and Mg(II)
could not substitute for ferrous ions when provided at 100 µM as chloride salts, and each inhibited HtxA activity by
about 10-30% when provided in addition to 100 µM
FeCl2 (Table II).
View this table:
[in this window]
[in a new window]
|
Table II
Effect of divalent cations on the activity of
2-oxoglutarate-dependent dioxygenase
The activity of HtxA was determined using the PtxD-coupled assay with 2 mM hypophosphite and 1 mM 2-oxoglutarate. The
results shown are the average of two experiments.
|
|
HtxA activity diminishes rapidly in assay buffer. Inactivation of other
2-oxoglutarate-dependent dioxygenases has been prevented by
the addition of ascorbate to the assay mixture, which is thought to
prevent oxidation of enzyme-bound ferrous ions, resulting in inactivation of the enzyme (24, 25). However, addition of ascorbate at
100 µM to the HtxA assay results in a 20% decrease in
specific activity. Furthermore, preincubation of HtxA in the reaction
mixture in the presence and absence of ferrous ions before assaying
enzyme activity resulted in an equally rapid decrease in HtxA activity.
Thus, HtxA inactivation in the reaction mixture is independent of the
presence of ferrous ions.
Kinetic Analysis of Hypophosphite Oxidation Catalyzed by
HtxA--
The oxidation of hypophosphite to phosphite by HtxA follows
Henri-Michaelis-Menten kinetics. The kinetic constants were determined using the continuous coupled assay with MBP-PtxD as the reporter enzyme. Vmax and kcat
were determined to be 10.9 ± 0.30 µmol min 1
mg 1 and 355 min 1, respectively (Fig.
6). The apparent
Km values were determined to be 0.58 ± 0.04 mM for hypophosphite (Fig. 6A) and
10.6 ± 1.4 µM for 2-oxoglutarate (Fig.
6B). To determine the very low Km of
2-oxoglutarate, a 5-cm path length cuvette was used to increase the
sensitivity of the assay.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Kinetic characterization of HtxA.
A, a substrate concentration curve for hypophosphite was
constructed, and the apparent Km for
hypophosphite was determined. The activity of HtxA was determined using
the PtxD-coupled assay in 20 mM MOPS, pH 7.0, containing 1 mM NAD+, 0.25 mM 2-oxoglutarate, 40 µM FeCl2, 391 µg of PtxD, 3.9 µg of HtxA,
and 0.18-3.0 mM hypophosphite. B, a substrate
concentration curve for 2-oxoglutarate was constructed, and the
apparent Km for 2-oxoglutarate was determined.
The activity assays were done using the PtxD-coupled assay in a 5-cm
path length cuvette. The assay contained 20 mM MOPS, pH
7.0, 10 mM hypophosphite, 1 mM
NAD+, 26 µM FeCl2, 1.5 units of
PtxD, 3.9 µg of HtxA, and a 2-oxoglutarate concentration range of
5.26-100 µM. All assays were performed in triplicate at
room temperature. The kinetic constants were determined with the
kinetic analysis program KINSIM (53).
|
|
Substrate and Cosubstrate Specificity of HtxA--
The substrate
specificity of HtxA was examined using an end point assay in which
accumulation of succinate was measured using a highly sensitive enzyme
assay for the detection of succinate (Table
III). Both inorganic and organic
compounds that are structurally analogous or that have similar
oxidation states to hypophosphite were examined. Of the alternative
substrates tested, sulfite, nitrite, methylphosphonate,
methylphosphinate, dimethylphosphinate, taurine, and formaldehyde were
not oxidized by HtxA. Formate and arsenite, and to a lesser extent,
phosphite, each yielded succinate after a prolonged incubation with 66 µg/ml HtxA and 4 mM substrate. Surprisingly, the amount
of succinate produced with formate and arsenite as substrates exceeded
that produced with hypophosphite as substrate. To address this further,
the specific activity of HtxA with each substrate supporting activity
was determined under conditions identical to those above with the
exception of the enzyme concentration, which was reduced to 19.3 µg/ml to slow the reaction enough to make the intermediate
measurements possible (Table III). With hypophosphite as the substrate,
the specific activity of HtxA was 11.0 units mg 1. The
specific activities acquired with formate and arsenite were 10.0 and
5.3 units mg-1, respectively. Activity was not detected
with phosphite as the substrate using this assay. Thus, HtxA
demonstrates relatively relaxed substrate specificity, being able to
oxidize several substrate analogs, a common characteristic among the
members of the 2-oxoglutarate-dependent dioxygenase
enzyme family (26-28).
View this table:
[in this window]
[in a new window]
|
Table III
Substrate range of 2-oxoglutarate-dependent
hypophosphite dioxygenase
Determination of HtxA activity with alternate substrates was done by
detection of succinate in an end point assay as described under
"Experimental procedures." The results shown are the average of two
experiments.
|
|
The cosubstrate range of HtxA was also examined (Table
IV). The continuous coupled assay was
used to determine whether other 2-oxoacids could support the oxidation
of hypophosphite. Among the alternative cosubstrates tested,
oxaloacetate, 2-oxovalerate, 2-oxocaproate, and 2-oxobutyrate could not
substitute for 2-oxoglutarate as cosubstrate, even when provided at 5 mM. At this concentration, only 2-oxoadipate, and to a much
lesser extent, pyruvate, resulted in the oxidation of hypophosphite.
When provided at 0.5 mM, only 2-oxoadipate supported HtxA
activity, resulting in about 37% of the activity observed with
2-oxoglutarate.
View this table:
[in this window]
[in a new window]
|
Table IV
Cosubstrate range of 2-oxoglutarate-dependent
hypophosphite dioxygenase
Determination of HtxA activity with alternate cosubstrates was done
using the PtxD-coupled assay as described. Hypophosphite was added at 2 mM, and the cosubstrates were added at the indicated
concentrations. The results shown are the average of two experiments.
|
|
Effects of Substrate Analogs and Reaction Products on the Activity
of HtxA--
Inhibition by substrate analogs was examined using the
continuous coupled HtxA activity assay (Table
V). The resulting specific activities
were compared with the activity observed with no inhibitor present. Of
the substrate analogs tested, nitrate and formate severely inhibited
HtxA activity, resulting in only 28.5 and 9.7% activity, respectively.
HtxA activity was only mildly inhibited by the presence of nitrite,
arsenite, sulfate, methylphosphonate, and aminoethylphosphonate.
Product inhibition was examined by adding succinate or phosphate to the
assay. The presence of phosphate slightly enhanced activity, whereas
succinate resulted in about 50% inhibition of HtxA activity.
View this table:
[in this window]
[in a new window]
|
Table V
Effect of product and substrate analog inhibitors on HtxA activity
HtxA activity was detected using the PtxD-coupled assay. The final
hypophosphite concentration was 0.5 mM and 2-oxoglutarate
was held at 0.25 mM. The results shown are the average of
two experiments.
|
|
The Expression of HtxA Is Phosphate
Starvation-inducible--
Because of the relaxed substrate specificity
of HtxA shown above, a genetic approach was taken to elucidate further
the in vivo role of this enzyme with regard to its
substrate. If the in vivo substrate of HtxA is an
alternative phosphorus source such as hypophosphite or phosphite, then
expression of HtxA might be induced under conditions of phosphate
starvation. To examine the regulation of expression of the
htx locus with growth on various phosphorus sources,
expression analysis from the htx promoter was performed in
P. stutzeri WM2940, which carries a plasmid-borne htx promoter-lacZ transcriptional fusion. With
growth on limiting phosphate, or on hypophosphite or phosphite as the
sole source of phosphorus with excess carbon, the expression of
-galactosidase from this fusion is induced 10-15-fold, relative to
expression with growth on excess phosphate. These data strongly suggest
a role for HtxA in acquiring an alternative source of phosphorus from
hypophosphite and phosphite and further support that hypophosphite is
the in vivo substrate of this enzyme.
 |
DISCUSSION |
Although there have been numerous accounts of microorganisms that
can grow on hypophosphite as the sole source of phosphorus, the
biochemical process by which this occurs had not been examined in
detail, leaving a novel and significant area of phosphorus metabolism
largely unexplored. The isolation and characterization of HtxA
presented in this paper represent the first detailed biochemical analysis of an enzyme in pure form devoted to the oxidation of the
reduced inorganic phosphorus compound, hypophosphite.
HtxA catalyzes the first reaction in a pathway required for the
acquisition of phosphate from the inorganic reduced phosphorus compound, hypophosphite. The biochemical characterization of HtxA presented here classifies this enzyme as a novel
2-oxoglutarate-dependent dioxygenase. This family of
enzymes is remarkably diverse in the reactions its members catalyze,
which include amino acid hydroxylations, secondary metabolite
biosynthesis, and degradation of alternative carbon and sulfur sources
(for review, see Refs. 29 and 30). The commonality among all of the
members of this family is that they all require activation of a
molecule of dioxygen by enzyme-bound ferrous ions to generate a highly
reactive ferryl oxidant. The formation of the ferryl species is linked
to the oxidative decarboxylation of 2-oxoglutarate, giving rise to
succinate and CO2, and mediates hydroxylation of the
substrate (31, 32). Thus, all members of this family are dependent on
ferrous ions, oxygen, and 2-oxoglutarate (or a similar 2-oxoacid) for
activity. Although the substrates acted upon by the members of this
family are diverse, all that have been characterized, to our knowledge,
act on organic substrates (29, 30). In contrast, of the substrates
tested in this study, HtxA showed the highest activity with the
inorganic substrate hypophosphite, making it the first enzyme in this
family to have an inorganic substrate. Several organic phosphorus
compounds thought to be possible alternative substrates for HtxA
(methylphosphinate, dimethylphosphinate, and methylphosphonate) were
not oxidized by this enzyme.
The low degree of amino acid sequence identity among
2-oxoglutarate-dependent dioxygenases mirrors their
catalytic diversity. Among the few highly conserved residues found in
many members of this family are those that have been identified to be
involved in binding of the ferrous ion. These residues form a conserved motif, designated the 2-His-1-carboxylate facial triad, typical of
non-heme Fe(II) enzymes (33). Advanced spectroscopic techniques (34),
site-directed mutagenesis studies (35-40), and examination of the
crystal structures of cephalosporin synthase and the mechanistically related, isopenicillin N synthase (41, 42), have further elucidated the
role of these residues in binding Fe(II), oxygen, and 2-oxoglutarate. The 2-His-1-carboxylate motif is also present in HtxA and its closest
sequence homologs (Fig. 7). Prolyl
4-hydroxylase shows the highest degree of sequence similarity to HtxA,
sharing 26% amino acid sequence identity. Phytanoyl-CoA hydroxylase
and an enzyme involved in mitomycin C biosynthesis, MmcH, share weaker homology to HtxA, with 23 and 22% identity, respectively. However, all
share a variation to the common
His-X-Asp-X53-57-His motif that is
characteristic to members of the 2-oxoglutarate-dependent dioxygenases superfamily and is thought to form the 2-His-1-carboxylate facial triad (Fig. 7 and Ref. 38). Within the group of HtxA homologs,
the histidine residues believed to be involved in Fe(II) binding are
spaced further apart in the amino acid sequence, giving a
His-X-Asp-X72-101-His-X10(Arg/Lys)X-Ser
motif that was found to be a distinct characteristic of this subgroup
of enzymes, which do not share significant homology to other members of
the 2-oxoglutarate-dependent dioxygenases family in the
data base (40). Other conserved residues are also evident within the
sequence of these proteins, but a function for these has yet to be
ascribed.

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 7.
Amino acid sequence alignment of HtxA with
members of the 2-oxoglutarate-dependent dioxygenase
superfamily. FASTA3 (54) searches using HtxA identified several
proteins sharing a significant degree of sequence identity from 22 to
26%. All are characterized or putative members of the
2-oxoglutarate-dependent dioxygenase superfamily. The top
three proteins were aligned with HtxA using ClustalW (55) and are as
follows: HtxA, 2-oxoglutarate-dependent hypophosphite
dioxygenase from P. stutzeri WM88; P4H,
L-proline 4-hydroxylase from Dactylosporangium
spp.; PAHX, phytanoyl-CoA dioxygenase from Homo sapiens;
MmcH, enzyme involved in mitomycin C biosynthesis from
Streptomyces lavendulae. Swiss Protein accession numbers for
the sequences used are O69060, O06499, O14832, and Q9X556,
respectively. Of the four enzymes shown, L-proline
4-hydroxylase has been studied the most extensively with regard to
residues involved in forming the ferrous ion binding site (35). The
residues comprise the 2-His-1-carboxylate facial triad (33) and are
conserved among these four proteins. They are indicated above the
corresponding residues in the alignment. The binding motif shared by
this subfamily of 2-oxoglutarate-dependent dioxygenases is
written above the conserved sequences (40). Strictly conserved residues
among the four proteins are shaded in dark gray. Similar
residues are light gray.
|
|
HtxA catalyzes a strictly coupled oxidation of hypophosphite, producing
equimolar amounts of succinate and phosphite, demonstrating the
expected stoichiometry of the 2-oxoglutarate-dependent
dioxygenase reaction. Interestingly, an uncoupled reaction of proline
4-hydroxylase has been well characterized, in which 2-oxoglutarate is
oxidatively decarboxylated to succinate and CO2, without
the concomitant hydroxylation of the substrate (24, 25, 43). However,
HtxA showed no such uncoupled reaction because succinate was not
produced upon incubation of the enzyme with 2-oxoglutarate in the
absence of hypophosphite.
The effect of ascorbate on HtxA activity was explored because it has
been reported to stabilize the activity of numerous members of this
family of enzymes during the reaction. This effect is attributed to the
role of ascorbate as a reducing agent that has been shown to counteract
Fe(II) oxidation to inactive Fe(III), believed to occur as a side
reaction during the hydroxylation of the substrate (24, 25, 44).
Stabilization of activity in the presence of ascorbate has been
observed in avian proline 4-hydroxylase (24, 25, 44) as well as in
other 2-oxoglutarate-dependent dioxygenases such as
desacetoxyvindoline 4-hydroxylase,
2,4-dichlorophenoxyacetate/2-oxoglutarate dioxygenase, oxygenative
alkylsulfatase, and 2-oxoglutarate-dependent taurine
dioxygenase (27, 30, 45, 46). In contrast, HtxA showed a marked
decrease in activity in the presence of ascorbate, further
demonstrating that the instability of the enzyme during the reaction is
independent of ferrous ion oxidation. The nature of the instability
appears to be simply the result of dilution of the enzyme, as has also
been observed in 2-oxoglutarte-dependent taurine
dioxygenase (27) and has not been explored further.
HtxA was able to catalyze the oxidation of both arsenite and formate,
although when comparing specific activities, hypophosphite was a
slightly better substrate. Arsenite and formate were among those chosen
as alternative substrates to examine based on their chemical and/or
similarity to hypophosphite. Given these similarities and the relaxed
substrate specificity observed in many of the members of this enzyme
family (27, 45, 46), it is not surprising that these compounds could be
oxidized. This is especially true in light of the highly reactive
dioxygen-derived ferryl species generated upon binding of
2-oxoglutarate and oxygen at the ferrous ion binding site thought to be
involved in the hydroxylation of the substrate (for review, see Refs.
29 and 47). To be oxidized via this reaction, the only requirement for
the compound would be that it fit into the active site in juxtaposition
with this highly reactive ferryl species. Given the similarities of
arsenite and formate to hypophosphite, this seems the most likely
explanation for the relaxed substrate specificity of HtxA. Because
formate can act as a substrate, it is also not surprising that formate significantly inhibits HtxA activity, probably because of competitive binding with hypophosphite at the active site. This further supports the conclusion that formate acts simply as a structural analog to
hypophosphite. The structural similarity between these two compounds
has been demonstrated previously by the ability of hypophosphite to act
as a substrate analog to both pyruvate formate lyase (48) and formate
hydrogenlyase and regulatory proteins involved in their expression
(49). Although the specific activity of HtxA with arsenite as a
substrate is significant, arsenite is a poor inhibitor of HtxA
activity, suggesting weak binding of arsenite in the active site
(relative to hypophosphite). Thus, arsenite is also probably not the
true substrate of HtxA. Considering both the biochemical evidence
presented here and the regulation of the htx and
ptx loci by phosphate starvation (this report and Ref. 15),
hypophosphite is almost certainly the in vivo substrate for
HtxA, with the role of providing P. stutzeri WM88 with an alternate phosphorus source via oxidation of inorganic reduced phosphorus compounds.
Compared with other members of the 2-oxoglutarate-dependent
dioxygenase enzyme family, HtxA shows somewhat strict cosubstrate specificity. Similar to taurine dioxygenase, HtxA was able to use only
2-oxoadipate to a significant degree in the place of 2-oxoglutarate
(27). This is in contrast to most members of this family, which are
able to use a broad range of 2-oxoacids, with or without a second
carboxyl group (45, 46). Both the cosubstrate specificity and the
apparent Km for 2-oxoglutarate fall within the
ranges observed for other members of this family.
Because of the dearth of knowledge regarding biological oxidation of
reduced phosphorus compounds and of the presence of these compounds in
the soil, examining the substrate specificity of HtxA was essential to
understanding the physiological role of this enzyme in phosphorus
metabolism. It is clear from the genetic analysis that the
htxA gene allows P. stutzeri WM88 to grow on hypophosphite as a sole phosphorus source and at a rate similar to
growth on phosphate (12). In addition, examination of the regulation of
expression of the ptx and htx operons indicates that both are highly expressed under conditions of phosphate
starvation, including growth on both limiting phosphate and on
hypophosphite or phosphite as the sole phosphorus sources. Sequence
analysis of the region upstream from the htxA translation
start site revealed the presence of a Pho box (data not shown), a
conserved binding sequence for transcriptional activation via PhoB
(50). In numerous microorganisms, PhoB is the response regulator
responsible for activating transcription of the Pho regulon, which is
comprised of numerous phosphate starvation-inducible loci, all involved in the assimilation of phosphorus in response to phosphate starvation. These genetic data strongly suggest that the in vivo role of
these genes is to allow use of an alternative phosphorus source, such as phosphite and hypophosphite.
What is less clear is the extent to which hypophosphite is present in
nature. Although it is widely used industrially as a reducing agent,
and microbe-mediated reduction of phosphate to phosphite,
hypophosphite, and phosphine has been reported (3, 51), no direct
measurements of inorganic reduced phosphorus compounds in the soil have
been documented. The apparent Km of HtxA for
hypophosphite of 0.58 mM is quite likely to be sufficiently low to support growth of this organism on even the very low
concentrations of hypophosphite one might expect to find in the
environment. This is particularly true given that htxA
appears to be cotranscribed with a binding protein-dependent
transporter that is required, in addition to htxA, for
growth on hypophosphite in the heterologous hosts, E. coli
and Pseudomonas aeruginosa (12). Such transporters are known
to be able to accumulate very high intracellular levels of their
substrate, with concentration gradients of up to 100,000-fold (52),
which would put intracellular hypophosphite concentrations well within
the range allowing HtxA to catalyze in vivo hypophosphite oxidation.
Finally, hypophosphite oxidation has been studied previously in
B. caldolyticus, and activity was found to be dependent on NAD+ (11), and anaerobic oxidation of hypophosphite has
been documented in uncharacterized Bacillus isolate (8). In
contrast to these findings, HtxA does not require NAD+ for
oxidation of hypophosphite, and oxygen is absolutely required for the
HtxA reaction. This indicates that HtxA is a very different enzyme from
those studied in two Bacillus species, supporting the
possible existence of multiple pathways for the oxidation of
hypophosphite in diverse microorganisms and the idea that hypophosphite oxidation is an important activity for survival in the environment. Given the large number and diversity of microorganisms reported to
oxidize hypophosphite or phosphite, it seems clear that oxidation of
reduced phosphorus compounds is not an uncommon activity and should be
considered a significant aspect of phosphorus biochemistry. A more
profound understanding of the environmental significance of reduced
phosphorus biochemistry and of the reaction mechanisms involved awaits
additional detailed analyses of the enzymes catalyzing these reactions
and of the genes encoding them.
 |
ACKNOWLEDGEMENTS |
We are grateful to the Miller Laboratory for
sharing of equipment and to Amaya Garcia Costas, Rachel Larson, Charles
Miller, Biswarup Mukhopadhyay, Ralph Wolfe, and Wilifred van der Donk for technical advice and many helpful discussions.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM59334. The Voyager mass spectrometer used by the University of
Illinois Mass Spectrometry facility was purchased in part with Division
of Research Resources, National Institutes of Health, Grant RR 11966.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Microbiology,
University of Illinois, B103 Chemical and Life Sciences Laboratory, 601 S. Goodwin Ave., Urbana, IL 61801. Tel.: 217-244-1943; Fax:
217-244-6697; E-mail: metcalf@uiuc.edu.
Published, JBC Papers in Press, August 2, 2002, DOI 10.1074/jbc.M204605200
 |
ABBREVIATIONS |
The abbreviations used are:
HtxA, hypophosphite:2-oxoglutarate dioxygenase;
BisTris, bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane;
CAPS, 3-(cyclohexylamino)propanesulfonic acid;
EDAC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide;
IPTG, isopropyl-1-thio- -D-galactopyranoside;
MES, 2-(N-morpholino)ethanesulfonic acid;
MBP, maltose-binding
protein;
MOPS, 3-(N-morpholino)propanesulfonic acid;
PtxD, NAD:phosphite oxidoreductase.
 |
REFERENCES |
| 1.
|
Casida, L. E., Jr.
(1960)
J. Bacteriol.
80,
237-241[Free Full Text]
|
| 2.
|
Malacinski, G.,
and Konetzka, W. A.
(1966)
J. Bacteriol.
91,
578-582[Abstract/Free Full Text]
|
| 3.
|
Tsubota, G.
(1959)
Soil Plant Food
5,
10-15
|
| 4.
|
Metcalf, W. W.,
and Wanner, B. L.
(1991)
J. Bacteriol.
173,
587-600[Abstract/Free Full Text]
|
| 5.
|
Kennedy, K. E.,
and Thompson, G. A., Jr.
(1970)
Science
168,
989-991[Abstract/Free Full Text]
|
| 6.
|
Adams, F.,
and Conrad, J. P.
(1953)
Soil Sci.
75,
361-371[CrossRef]
|
| 7.
|
Lauwers, A. M.,
and Heinen, W.
(1977)
Arch. Microbiol.
112,
103-107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Foster, T. L.,
Winans, L., Jr.,
and Helms, S. J.
(1978)
Appl. Environ. Microbiol.
35,
937-944[Abstract/Free Full Text]
|
| 9.
|
Imazu, K.,
Tanaka, S.,
Kuroda, A.,
Anbe, Y.,
Kato, J.,
and Ohtake, H.
(1998)
Appl. Environ. Microbiol.
64,
3754-3758[Abstract/Free Full Text]
|
| 10.
|
Malacinski, G. M.,
and Konetzka, W. A.
(1967)
J. Bacteriol.
93,
1906-1910[Abstract/Free Full Text]
|
| 11.
|
Heinen, W.,
and Lauwers, A. M.
(1974)
Arch. Microbiol.
95,
267-274[CrossRef]
|
| 12.
|
Metcalf, W. W.,
and Wolfe, R. S.
(1998)
J. Bacteriol.
180,
5547-5558[Abstract/Free Full Text]
|
| 13.
|
Shibasaki, T.,
Mori, H.,
Chiba, S.,
and Ozaki, A.
(1999)
Appl. Environ. Microbiol.
65,
4028-4031[Abstract/Free Full Text]
|
| 14.
|
Vrtis, J. M.,
White, A. K.,
Metcalf, W. W.,
and van der Donk, W. A.
(2001)
J. Am. Chem. Soc.
123,
2672-2673[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Costas, A. M.,
White, A. K.,
and Metcalf, W. W.
(2001)
J. Biol. Chem.
276,
17429-17436[Abstract/Free Full Text]
|
| 16.
|
Grant, S. G. N.,
Jessee, J.,
Bloom, F. R.,
and Hanahan, D.
(1990)
Proc. Natl. Acd. Sci. U. S. A.
87,
4645-4649[Abstract/Free Full Text]
|
| 17.
|
Studier, F. W.,
Rosenberg, A. H.,
Dunn, J. J.,
and Dubendorff, J. W.
(1990)
Methods Enzymol.
185,
60-89[Medline]
[Order article via Infotrieve]
|
| 18.
|
Wanner, B. L.
(1986)
J. Mol. Biol.
191,
39-58[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1992)
Current Protocols in Molecular Biology
, John Wiley & Sons, Inc., New York
|
| 20.
|
Metcalf, W. W.,
Jiang, W.,
Daniels, L. L.,
Kim, S. K.,
Haldimann, A.,
and Wanner, B. L.
(1996)
Plasmid
35,
1-13[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Larsen, R. A.,
Wilson, M. M.,
Guss, A. M.,
and Metcalf, W. W.
(2002)
Arch. Microbiol.
178,
193-201[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Ellis, K. J.,
and Morrison, J. F.
(1982)
Methods Enzymol.
87,
405-426[Medline]
[Order article via Infotrieve]
|
| 23.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
de Jong, L.,
Albracht, S. P. J.,
and Kemp, A.
(1982)
Biochim. Biophys. Acta
704,
326-332[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Nietfeld, J. J.,
and Kemp, A.
(1981)
Biochim. Biophys. Acta
657,
159-167[Medline]
[Order article via Infotrieve]
|
| 26.
|
Hogan, D. A.,
Auchtung, T. A.,
and Hausinger, R. P.
(1999)
J. Bacteriol.
181,
5876-5879[Abstract/Free Full Text]
|
| 27.
|
Eichhorn, E.,
van der Ploeg, J. R.,
Kertesz, M. A.,
and Leisinger, T.
(1997)
J. Biol. Chem.
272,
23031-23036[Abstract/Free Full Text]
|
| 28.
|
Fukumori, F.,
and Hausinger, R. P.
(1993)
J. Bacteriol.
175,
2083-2086[Abstract/Free Full Text]
|
| 29.
|
Prescott, A. G.,
and Lloyd, M. D.
(2000)
Nat. Prod. Rep.
17,
367-383[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
De Carolis, E.,
and De Luca, V.
(1994)
Phytochemistry
36,
1093-1107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Blanchard, J. S.,
and Englard, S.
(1983)
Biochemistry
22,
5922-5929[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Hanauske-Abel, H. M.
(1982)
J. Theor. Biol.
94,
421-455[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Hegg, E. L.,
and Que, L.
(1997)
Eur. J. Biochem.
250,
625-629[Medline]
[Order article via Infotrieve]
|
| 34.
|
Hegg, E. L.,
Whiting, A. K.,
Saari, R. E.,
McCracken, J.,
Hausinger, R. P.,
and Que, L., Jr.
(1999)
Biochemistry
38,
16714-16726[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Lamberg, A.,
Pihlajaniemi, T.,
and Kivirikko, K. I.
(1995)
J. Biol. Chem.
270,
9926-9931[Abstract/Free Full Text]
|
| 36.
|
Pirskanen, A.,
Kaimio, A.-M.,
Myllyla, R.,
and Kivirikko, K. I.
(1996)
J. Biol. Chem.
271,
9398-9402[Abstract/Free Full Text]
|
| 37.
|
Lukacin, R.,
and Britsch, L.
(1997)
Eur. J. Biochem.
249,
748-757[Medline]
[Order article via Infotrieve]
|
| 38.
|
Borovok, I.,
Landman, O.,
Kreisberg Zakarin, R.,
Aharonowitz, Y.,
and Cohen, G.
(1996)
Biochemistry
35,
1981-1987[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Khaleeli, N.,
Busby, R. W.,
and Townsend, C. A.
(2000)
Biochemistry
39,
8666-8673[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Hogan, D. A.,
Smith, S. R.,
Saari, E. A.,
McCracken, J.,
and Hausinger, R. P.
(2000)
J. Biol. Chem.
275,
12400-12409[Abstract/Free Full Text]
|
| 41.
|
Roach, P. L.,
Clifton, I. J.,
Hensgens, C. M.,
Shibata, N.,
Schofield, C. J.,
Hajdu, J.,
and Baldwin, J. E.
(1997)
Nature
387,
827-830[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Valegard, K.,
van Scheltinga, A. C.,
Lloyd, M. D.,
Hara, T.,
Ramaswamy, S.,
Perrakis, A.,
Thompson, A.,
Lee, H. J.,
Baldwin, J. E.,
Schofield, C. J.,
Hajdu, J.,
and Andersson, I.
(1998)
Nature
394,
805-809[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Lawrence, C. C.,
Sobey, W. J.,
Field, R. A.,
Baldwin, J. E.,
and Schofield, C. J.
(1996)
Biochem. J.
313,
185-191
|
| 44.
|
Myllyla, R.,
Kuutti-Savolainen, E.-R.,
and Kivirikko, K. I.
(1978)
Biochem. Biophys. Res. Commun.
83,
441-448[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Fukumori, F.,
and Hausinger, R. P.
(1993)
J. Biol. Chem.
268,
24311-24317[Abstract/Free Full Text]
|
| 46.
|
Kahnert, A.,
and Kertesz, M. A.
(2000)
J. Biol. Chem.
275,
31661-31667[Abstract/Free Full Text]
|
| 47.
|
Que, L. J.,
and Ho, R. Y. N.
(1996)
Chem. Reviews
96,
2607-2624[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Plaga, W.,
Frank, R.,
and Knappe, J.
(1988)
Eur. J. Biochem.
178,
445-450[Medline]
[Order article via Infotrieve]
|
| 49.
|
Hopper, S.,
Babst, M.,
Schlensog, V.,
Fischer, H. M.,
Hennecke, H.,
and Bock, A.
(1994)
J. Biol. Chem.
269,
19597-19604[Abstract/Free Full Text]
|
| 50.
|
Makino, K.,
Shinagawa, H.,
Amemura, M.,
and Nakata, A.
(1986)
J. Mol. Biol.
192,
549-556[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Devai, I.,
Felfoldy, L.,
Wittner, I.,
and Plosz, S.
(1988)
Nature
333,
343-345[CrossRef]
|
| 52.
|
Szmelcman, S.,
Schwartz, M.,
Silhavy, T. J.,
and Boos, W.
(1976)
Eur. J. Biochem.
65,
13-19[Medline]
[Order article via Infotrieve]
|
| 53.
|
Barshop, B. A.
(1983)
Anal. Biochem.
130,
134-145[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Pearson, W. R.,
and Lipman, D. J.
(1988)
Proc. Natl. Acd. Sci. U. S. A.
85,
2444-2448[Abstract/Free Full Text]
|
| 55.
|
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. A. Muller, T. Fleischmann, J. R. van der Meer, and H.-P. E. Kohler
Purification and Characterization of Two Enantioselective {alpha}-Ketoglutarate-Dependent Dioxygenases, RdpA and SdpA, from Sphingomonas herbicidovorans MH.
Appl. Envir. Microbiol.,
July 1, 2006;
72(7):
4853 - 4861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Wilson and W. W. Metcalf
Genetic Diversity and Horizontal Transfer of Genes Involved in Oxidation of Reduced Phosphorus Compounds by Alcaligenes faecalis WM2072
Appl. Envir. Microbiol.,
January 1, 2005;
71(1):
290 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. White and W. W. Metcalf
The htx and ptx Operons of Pseudomonas stutzeri WM88 Are New Members of the Pho Regulon
J. Bacteriol.,
September 1, 2004;
186(17):
5876 - 5882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. White and W. W. Metcalf
Two C--P Lyase Operons in Pseudomonas stutzeri and Their Roles in the Oxidation of Phosphonates, Phosphite, and Hypophosphite
J. Bacteriol.,
July 15, 2004;
186(14):
4730 - 4739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yang and W. W. Metcalf
A new activity for an old enzyme: Escherichia coli bacterial alkaline phosphatase is a phosphite-dependent hydrogenase
PNAS,
May 25, 2004;
101(21):
7919 - 7924.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|